Perman Jorayev

Perman Jorayev, Ph.D., is an experienced investor with a focus on various innovative companies. Current investment roles include positions at Amadeus Capital Partners and Nuclera, as well as significant involvement with Orakl Oncology and Multiomic Health as both an investor and board observer. Additionally, Perman Jorayev serves as an investor and board observer for Zero Point Motion, demonstrating a strong commitment to fostering growth in the technology and health sectors.